{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:30:58Z","timestamp":1761870658939,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.clml.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T14:53:09Z","timestamp":1411915989000},"page":"e55-e60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Stefano","family":"Molica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Levato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.clml.2014.09.003_bib1"},{"key":"10.1016\/j.clml.2014.09.003_bib2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib3","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib4","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2012-01-404681","article-title":"Monoclonal B-cell lymphocytosis: right track or red herring?","volume":"119","author":"Ghia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib5","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2008-09-176149","article-title":"B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome","volume":"113","author":"Shanafelt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.09.003_bib7","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-12-471698","article-title":"Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL","volume":"121","author":"Vardi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2010.030189","article-title":"Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group","volume":"96","author":"Molica","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2014.09.003_bib9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/10428190701321277","article-title":"Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis","volume":"48","author":"Fung","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2014.09.003_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.09.003_bib11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/leu.2012.20","article-title":"Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?","volume":"26","author":"Scarf\u00f2","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2014.09.003_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2011.09010.x","article-title":"Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL","volume":"157","author":"Kern","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.09.003_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hoc.2013.01.004","article-title":"MBL versus CLL: how important is the distinction?","volume":"27","author":"Scarf\u00f2","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clml.2014.09.003_bib14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2002-12-3639","article-title":"Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features","volume":"102","author":"Guarini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib15","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1158\/1078-0432.CCR-13-0622","article-title":"Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features","volume":"19","author":"Morabito","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2014.09.003_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830290307","article-title":"Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group","volume":"29","author":"Cheson","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2014.09.003_bib17","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3324\/haematol.11646","article-title":"Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70\u2013positive cells","volume":"93","author":"Cutrona","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2014.09.003_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clml.2014.09.003_bib20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/gcc.20579","article-title":"Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia","volume":"47","author":"Fabris","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2014.09.003_bib21","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.2008.21.2704","article-title":"Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia","volume":"27","author":"Shanafelt","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2014.09.003_bib22","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.003_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2011.053090","article-title":"Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis","volume":"97","author":"Rasi","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2014.09.003_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hon.2013","article-title":"Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis","volume":"31","author":"Greco","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2014.09.003_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2013.08.003","article-title":"Monoclonal B cell lymphocytosis and \u201cin situ\u201d lymphoma","volume":"24","author":"Karube","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.clml.2014.09.003_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.leukres.2006.07.006","article-title":"Is \u201cleukemia\u201d an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?","volume":"31","author":"Hoffbrand","year":"2007","journal-title":"Leuk Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:11Z","timestamp":1761870371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014004133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2152265014004133"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.09.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Biologic Parameters Affect the Time to First Treatment of Clinical Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia Rai Stage 0? Results of a Prospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}